SAN FRANCISCO - Augmedix Inc. (NASDAQ:AUGX), a provider of AI-driven medical documentation services, announced today the appointment of Alex Stinard, M.D., as its new Chief Clinical AI Officer. Dr. Stinard, with over 20 years of experience in emergency medicine and expertise in data science, will lead the company's efforts in enhancing AI technology for clinical practices.
Dr. Stinard's background combines emergency medicine with a specialization in large language models, computer vision, and natural language processing. This combination positions him to integrate advanced AI solutions into healthcare, aiming to alleviate clinicians from the administrative burden and enhance patient care.
Manny Krakaris, CEO of Augmedix, expressed enthusiasm about Dr. Stinard's appointment, emphasizing his understanding of AI's potential in healthcare and its role in improving clinical efficiency. Dr. Stinard will continue to serve as the Regional Medical Director of Emergency Medicine at HCA Healthcare (NYSE:HCA) in Orlando, Florida, while taking on his new responsibilities at Augmedix.
In his statement, Dr. Stinard highlighted the opportunity to apply his experience towards advancing AI in healthcare, aiming to restore the joy of practicing medicine for clinicians and improving patient outcomes. His role will focus on the development and expansion of AI solutions to tackle major challenges faced by clinicians and health systems.
Augmedix's platform is designed to transform natural conversations into organized medical notes and structured data, providing real-time support for doctors. The company collaborates with hospitals and health systems to enhance clinical workflows and integrate clinician judgment comprehensively.
The announcement represents Augmedix's commitment to improving the patient experience at the point of care, increasing productivity through better documentation quality, and reducing cognitive load for clinicians. Dr. Stinard's forward-thinking approach is expected to spearhead initiatives that elevate clinical workflows and patient care.
This news is based on a press release statement and includes forward-looking statements that involve risks and uncertainties. The forward-looking statements reflect Augmedix's views as of the date of the press release and are subject to change. Investors and media are advised that actual results may differ materially from those projected in the statements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.